Pharmacological secondary prevention in people with peripheral arterial disease compared to those with coronary artery disease: A missed opportunity

British Journal of Cardiology

Volumn 15, Issue 1, 2008, Pages 48-50

  Janes, Simon E J ^a,b   West, Joe ^a   Hopkinson, Brian R ^a   Walsh, John T ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Coronary artery disease; Peripheral arterial disease; Secondary prevention; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTERY DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG USE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION;

EID: 39849084093     PISSN: 09696113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Mukherjee D, Lingham P, Chetcuti S et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-Q12). Circulation 2002;106:1909-12.
2. CAPRIE steering committee. A randomised, blinded trial of clopidogrel vs aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348: 1329-39.
3. The Heart Outcomes Prevention Evaluation Study investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000;342:145-53.
4. Pedersen TR, Kjekshus J, Pyorala K et al. Effect of simvastatin on ischaemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 1998;81:333-5.
5. Mc Grae Mc Dermott M, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997;12:209-15.